BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 5, 2020
View Archived Issues
CRISPR sheds LICHT on brain development
Read More
Macrophages metabolically support muscle
Read More
Seeing where tau goes wrong
Read More
Hoth outlines progress within COVID-19 pipeline
Read More
Sorrento Therapeutics synthesizes multispecific antigen-binding protein complexes
Read More
New anti-CD40 antibodies described by Nankai University
Read More
Memorial Sloan-Kettering Cancer Center presents CD19 antibodies
Read More
New wee1-like protein kinase inhibitors discovered at Nuvation Bio
Read More
Roche identifies new monoglyceride lipase inhibitors
Read More
Preliminary first-in-human data for [11C]MeDAS PET tracer
Read More
BlueWillow Biologics presents preclinical data on NanoVaz and S-2P-NE01
Read More
Discovery of novel DNA-PK inhibitors as radiosensitizers
Read More
[68Ga]Desferal developed for imaging of bacterial infections
Read More
Calithera expands phase I/II trial of telaglenastat with palbociclib to include pancreatic cancer
Read More
First results for KSQ-4279 in treatment of BRCA-deficient cancers
Read More
Microbiome confounders research complicates control groups
Read More
PK and safety data for nacubactam in combination with beta-lactams
Read More
Phase IIb/III study opens in U.S. with mesdopetam for troublesome dyskinesias in Parkinson's
Read More
[18F]FSU-880 imaging evaluated in prostate cancer patients with biochemical recurrence
Read More
Hangzhou Zhengxiang Pharmaceuticals patents PI3K-gamma inhibitors
Read More
Synlogic advances SYNB-8802 into phase I study for treatment of enteric hyperoxaluria
Read More
E.U. approval of Lynparza with bevacizumab for first-line maintenance in HRD-positive ovarian cancer
Read More
Chinese clearance for phase III trial of APL-1202 for first-line nonmuscle invasive bladder cancer
Read More